Peripheral Angioplasty Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Autologous CD133(+) Cells as an Adjuvant to Below the Knee (BTK) Percutaneous Transangioplasty (PTA)
Condition: Peripheral Arterial Disease Interventions: Biological: G-CSF + CD133(+) cells; Biological: G-CSF; Procedure: percutaneous transluminal angioplasty (PTA); Biological: Placebo infusion Sponsor: Shanghai 10th People's Hospital Recruiting - verified September 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2016 Category: Research Source Type: clinical trials
Autologous CD133(+) Cells as an Adjuvant to Below the Knee Percutaneous Transluminal Angioplasty
Condition: Peripheral Arterial Disease Interventions: Biological: G-CSF + CD133(+) cells; Biological: G-CSF; Procedure: percutaneous transluminal angioplasty (PTA); Biological: Placebo infusion Sponsor: Shanghai 10th People's Hospital Recruiting - verified September 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2016 Category: Research Source Type: clinical trials
